Name | [(2R,3R)-2-[1-[(2R,3R)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-3,4,5-trihydroxy-6-oxobenzo[7]annulen-8-yl]-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate |
---|---|
Synonyms |
8-Gingerol
(3,4,5-Trihydroxy-6-oxo-6H-benzo[7]annulene-1,8-diyl)bis[(2R,3R)-5,7-dihydroxy-3,4-dihydro-2H-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate) theaflavin 3,3'-O-digallate Theaflavin-3,3'-digallate theaflavin-3,3'-di-O-gallate theaflavin 3,3'-gallate Benzoic acid, 3,4,5-trihydroxy-, (3,4,5-trihydroxy-6-oxo-6H-benzocycloheptene-1,8-diyl)bis[(2R,3R)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-2,3-diyl] ester Theaflavin digallate TF-3 Theaflavin 3,3'-digallate |
Description | Theaflavin 3,3'-digallate (TF3), the typical pigment in black tea, is a good antitumor agent. Theaflavin 3,3'-digallate is generally regarded as the effective component for the inhibitory effects against carcinogenesis without adverse side effects by affecting multiple signal transduction pathways, such as upregulating p53 and p21, inhibiting phosphorylation of the cell survival protein Akt and MAPK pathway, downregulation of NF-κB, shifting the ratio between pro-/antiapoptotic proteins. Theaflavin 3,3'-digallate causes a rapid and sustained decrease in phospho-ERK1/2 and -MEK1/2 protein expression. Theaflavin 3,3'-digallate inhibits HCT116 cell growth with an IC50 of 17.26 μM[1]. |
---|---|
Related Catalog | |
Target |
Akt NF-κB MEK1 MEK2 ERK1 ERK2 |
References |
Density | 2.0±0.1 g/cm3 |
---|---|
Boiling Point | 1324.7±65.0 °C at 760 mmHg |
Melting Point | 226-230℃ |
Molecular Formula | C43H32O20 |
Molecular Weight | 868.702 |
Flash Point | 402.9±27.8 °C |
Exact Mass | 868.148682 |
PSA | 351.12000 |
LogP | 3.88 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.908 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
HS Code | 29329990 |